Royal Bank of Canada (RY)
180.38
+0.26 (0.14%)
TSX · Last Trade: Jul 8th, 3:44 PM EDT
Detailed Quote
Previous Close | 180.12 |
---|---|
Open | 180.03 |
Bid | 180.36 |
Ask | 180.40 |
Day's Range | 179.87 - 180.84 |
52 Week Range | 145.58 - 181.88 |
Volume | 928,442 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 2,630,976 |
Chart
About Royal Bank of Canada (RY)
Royal Bank of Canada is a leading financial services institution that provides a wide range of banking and financial solutions to individuals, businesses, and institutions. The bank offers personal and commercial banking services, wealth management, investment banking, and capital markets services. With a robust network of branch locations and digital platforms, it aims to meet the diverse needs of its clients while focusing on innovation and customer service. Royal Bank of Canada is committed to enhancing the financial well-being of its customers and leveraging its expertise to support economic growth in the communities it serves. Read More
News & Press Releases
VANCOUVER, British Columbia – July 8th, 2025 – Integrated Cyber Solutions Inc. (CSE:ICS) (OTCQB:IGCRF) (“ICS” or the “Company”) is pleased to announce the formation of its Cyber Future Advisory Board , a newly established group created to guide the Company’s strategy as it expands into emerging areas of cybersecurity and prepares for the coming impact … Continue reading "Integrated Cyber Solutions Welcomes Peter Buckley, Former Head of Cybersecurity at HSBC Canada, to Newly Formed Cyber Future Advisory Board, and Announces Engagement of Investor Relations Personnel, Entrance Into Debt Settlement, Adoption of Omnibus Equity Incentive Plan"
Via PressReach · July 8, 2025
Lincoln Financial Group’s first quarter results prompted a modestly negative market reaction, as investors weighed solid adjusted earnings against a notable miss on operating income versus Wall Street expectations. Management pointed to steady progress in diversifying the business mix, particularly with margin expansion in Group Protection and strong annuity sales, but acknowledged ongoing market volatility and the impact of lower alternative investment returns. CEO Ellen Cooper described the quarter as “another solid quarter” and emphasized the company’s focus on operational efficiency and capital strength in light of continued macroeconomic uncertainty.
Via StockStory · July 8, 2025
The company anticipates a research expense in Q2 associated with milestone and licensing payments, which will impact both GAAP and non-GAAP earnings per share.
Via Stocktwits · July 7, 2025
Via The Motley Fool · July 6, 2025
Goldman Sachs’ new price target represents a 0.2% downside from TSLA’s closing price on Wednesday.
Via Stocktwits · July 3, 2025
Via The Motley Fool · July 2, 2025
The bullish call follows RBC’s recent initiation at ‘Outperform’ and comes as Autoliv maintains its 2025 margin and growth targets.
Via Stocktwits · July 1, 2025
RBC Bearings’ first quarter saw a positive market response despite missing Wall Street’s revenue target, as strong demand in both its aerospace and industrial segments drove year-on-year sales growth. Management attributed the performance to robust gains in commercial aerospace, defense, and a notable turnaround in industrial operations, particularly through targeted service level improvements and new product introductions. CEO Michael Hartnett credited the breadth of RBC’s portfolio, as well as organic growth initiatives with key customers, for helping the company outperform broader industrial trends and expand gross margins. He also noted, “Our outgrowth relative to peers and the broader industrial economy has been notable.”
Via StockStory · June 30, 2025
Via The Motley Fool · June 29, 2025
Bill Meury previously led Karuna Therapeutics through a $14 billion sale to Bristol Myers Squibb and steered Anthos Therapeutics ahead of its acquisition by Novartis.
Via Stocktwits · June 27, 2025
The offering follows an upward revision to CorMedix’s Q2 revenue forecast, driven by faster-than-expected rollout of its FDA-approved DefenCath therapy across an extensive dialysis network.
Via Stocktwits · June 27, 2025
The new price target represents a 45% upside to the stock’s closing price on Wednesday and follows the EV maker’s successful pilot launch of its robotaxis in Austin over the weekend.
Via Stocktwits · June 26, 2025
Bill Meury will take the place of Herve Hoppenot, who is retiring after 11 years at Incyte's helm.
Via Investor's Business Daily · June 26, 2025
The equity raise comes as Kratos expands its role in next-gen defense systems, including a new propulsion partnership with GE Aerospace and growing investor interest driven by bullish analyst coverage.
Via Stocktwits · June 26, 2025
RBC Capital Markets analyst David Paige reiterated an Outperform rating on TD Synnex and maintained a $145 price forecast.
Via Benzinga · June 25, 2025
Analysts are cautiously optimistic on BlackBerry, citing stronger pipeline visibility with QNX and IoT viewed as key growth drivers after its Q1 earnings beat estimates.
Via Stocktwits · June 25, 2025
Today's high-octane AI stocks could be some of the worst performers over the next year, based on the forecasts of select analysts.
Via The Motley Fool · June 25, 2025
The offering is being led by J.P. Morgan, Morgan Stanley, Guggenheim Securities, and Cantor.
Via Stocktwits · June 23, 2025
CorMedix shares bounded to a four-year high Monday after the biotech company inked an expanded deal for its leading drug.
Via Investor's Business Daily · June 23, 2025
Single doses of 450mg, 300mg, and 150mg of CD388 conferred 76%, 61%, and 58% protection, respectively, from symptomatic influenza over 24 weeks compared to placebo, the company said.
Via Stocktwits · June 23, 2025
RBC maintains Outperform rating on CarMax, raises price target to $81. Q1 earnings beat estimates with strong sales growth, market share gains, and cost management efforts.
Via Benzinga · June 23, 2025
Toronto, Ontario - In a world increasingly shaped by fast-moving data and ever-shifting customer expectations, Melissa Sanasie, an accomplished marketing leader with over 12 years of experience, is calling on marketing professionals to sharpen both sides of their craft: data literacy and creative strategy.
Via Get News · June 23, 2025
The midstage study hit all its goals, representing a "best case" scenario, according to one analyst.
Via Investor's Business Daily · June 23, 2025
While many analysts on Wall Street have raised their price targets on GMS after The Wall Street Journal’s report that Home Depot may have submitted a competing bid against QXO, RBC Capital said the lack of details “raises questions.”
Via Stocktwits · June 20, 2025